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Bacteria within the Mycobacterium avium complex are prominent in the environment and are a source of
serious disseminated infections in patients with AIDS. Serovars of the M. avium complex are distinguished from
all other mycobacteria and from one another by the presence of highly antigenic glycolipids, the glycopepti-
dolipids, on their surfaces. A genomic library of DNA from serovar 2 of the M. avium complex was constructed
in the Escherichia coli-Mycobacterium shuttle cosmid, pYUB18, and used to clone and express in Mycobacte-
rium smegmatis the genes responsible for the biosynthesis of the oligosaccharide segment of the M. avium
serovar 2-specific glycopeptidolipid. The responsible gene cluster was mapped to a 22- to 27-kb functional
region of the M. avium genome. The recombinant glycolipid was also isolated by high-pressure liquid
chromatography and chemically characterized, by gas chromatography-mass spectrometry and fast atom
bombardment-mass spectrometry, to demonstrate that the lipopeptide core originated in M. smegmatis,
whereas the oligosaccharide segment arose from the cloned M. avium genes. This first-time demonstration of
the cloning and expression, in a nonpathogenic mycobacterium, of the genes encoding complex cell wall
glycoconjugates from a pathogenic mycobacterium presents a new approach for studying the role of such
products in disease processes.
Since the time of their recognition until recently, Myco-
bacterium avium organisms have seldom been associated
with severe life-threatening, disseminated infections in hu-
mans (30). However, it is now recognized that the most
frequently encountered bacterial infections in patients with
AIDS are due to members of the M. avium complex (10, 23).
The single most distinguishing feature of M. avium is the
copious amounts of highly antigenic glycolipids, the glyco-
peptidolipids (GPLs), present on the bacterium's surface (5,
20). Other than these, the cell walls of M. avium apparently
display an architecture that is common to the genus (11). The
GPLs which distinguish the 30-odd serovars of the M. avium
complex and bear responsibility for their serotypic differ-
ences are multiglycosylated at the threonine substituent of
an otherwise invariant lipopeptide core (Fig. 1). An extraor-
dinary array of sugars within this variable oligosaccharide
region confer serological specificity; the structure of the
serospecific GPL of serovar 2 (ssGPL-2) (9) is shown in Fig.
1A. In addition, all members of the M. avium complex
contain simpler, nonspecific GPLs (nsGPLs) which dilfer
from the ssGPLs in that they are singly glycosylated at the
threonine substituent with either 6-deoxytalose or 3-0-
methyl-6-deoxytalose (5, 6). While considerable effort has
been devoted to structural elucidation of the GPLs, their
biosynthesis and roles in drug permeability and disease
pathogenesis have barely been addressed (7). The fact that
Mycobacterium smegmatis, unlike M. avium, is now ame-
nable to genetic transfer systems (26, 27) provides a unique
opportunity to clone the DNA responsible for the synthesis
of complex secondary gene products associated with the cell
* Corresponding author.
walls of pathogenic M. avium. The added fact that M.
smegmatis contains the simpler, singly glycosylated nsGPLs
(Fig. 1B) and is devoid of the multiglycosylated ssGPLs (1,
12) also presented the opportunity to express in another
mycobacterium the particular gene cluster responsible for
the biosynthesis of the serovar 2-specific sugar segment of its
ssGPL. These experiments have set the stage for a new
generation of studies of the biosynthesis and function of not
only the GPLs but also those other mycobacterial cell wall
products that distinguish pathogenic from nonpathogenic
mycobacteria.
MATERIALS AND METHODS
Bacterial strains and other materials. Escherichia coli
X2764 and X2819 were used for transduction and amplifica-
tion of the M. avium cosmid library (15). The M. avium
serovar 2 strain TMC 724 was the source of genomic DNA.
M. smegmatis mc2155 (27) was used for electroporation and
subsequent expression of the recombinant serovar 2-specific
GPL (R-ssGPL-2).
Restriction endonucleases, calf intestine alkaline phos-
phatase, and T4 ligase were purchased from Boehringer
Mannheim Biochemicals (Indianapolis, Ind.), New England
Biolabs, Inc. (Beverly, Mass.), and Bethesda Research
Laboratories (Gaithersburg, Md.). Lysozyme, lipase, and
proteinase K were purchased from Sigma Chemical Co. (St.
Louis, Mo.). The Genius kit from Boehringer Mannheim
Biochemicals was employed in the preparation of nonradio-
active DNA probes.
DNA and cosmid isolation. Genomic DNA was isolated
from Mycobacterium spp. by using slight modifications of
the method of Whipple et al. (29). Cell pellets stored at
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Serovar Specific GPL-2 from M. avium Serovar 2
Fatty acyl - NH - D - Phe - D - aThr - D - Ala - L - Alaninol - 0 - (3,4 - Me2 - Rha)
0U
6-dTal - Rha - 2,3 - Me2 - Fuc
Non-Specific GPL from M. smegmatis
Fatty acyl - NH - D - Phe - D - aThr - D - Ala - L - Alaninol -0 -(2,3,4 -Me3 - Rha)
0U
6-dTal
FIG. 1. Structures of native GPLs. (A) Structure of the multiglycosylated M. avium ssGPL-2 (9). (B) Structure of one of the singly
glycosylated nsGPLs of M. smegmatis (analogous structures with different fatty acyl and sugar substitutions are present in all serovars of the
M. avium complex) (22).
-70°C were thawed and washed once in 50 mM Tris-HCI
(pH 8.0)-10 mM EDTA-100 mM NaCI. The washed cells
were suspended at a concentration of 200 mg (wet weight) of
cells per ml of buffer. Lipase was added to a final concen-
tration of 8,000 U/ml, and the mixture was incubated at 37°C
for 2 h on a rocking platform. The addition of lysozyme to a
final concentration of S mg/ml was followed by incubation
for 1.5 h at 37°C. Proteinase K and sodium dodecyl sulfate
(SDS) were added to final concentrations of 0.2 mg/ml and
1% (wt/vol), respectively. The suspension was incubated for
6 to 8 h at 55°C and chilled for 15 min. The lysates were
extracted three times with phenol-CHC13-isoamyl alcohol
(25:24:1) and then once with CHCl3-isoamyl alcohol (24:1).
The DNA was precipitated and treated with RNase A
according to the method of Maniatis et al. (19).
The pYUB18 cosmid and recombinant derivatives were
isolated from E. coli by the standard alkaline-SDS method
(19). Recombinant cosmids from M. smegmatis were iso-
lated in like fashion except that lysozyme digestion lasted for
1 h at 37°C and the NaOH-SDS treatment lasted for 45 min
at 600C.
Construction of the M. avium cosmid library. An E. coli-
Mycobacterium shuttle cosmid (pYUB18) was constructed
by inserting the lambda cos sequence into the E. coli-
Mycobacterium shuttle plasmid pYUB12 (1Sa, 26). Genomic
DNA from M. avium serovar 2 strain TMC 724 was sub-
jected to partial Sau3A digestion. DNA fragments ranging
from 32 to 40 kb were isolated from a preparative 0.4%
agarose gel by electroelution and ligated into the BamHI site
of the pYUB18 vector (15a, 19). The ligation mixture was
packaged into lambda phage particles by using the Giga Pack
Plus system from Stratagene (La Jolla, Calif.). The phage
particles were subsequently used to transduce E. coli X2819
cells (15). Infected cells were plated on Luria-Bertani plates
containing 25 jig of kanamycin per ml and grown at 30°C.
Kanamycin-resistant colonies were pooled and grown to
mid-log phase at 30°C for isolation of the cosmid library as
plasmid. For storage, in vivo packaging was induced in the
X2819 cells and the library was isolated as transducing-
particle lysate (15).
Screening of the M. avium serovar 2 cosmid library. The M.
avium serovar 2 cosmid library isolated as plasmid DNA was
electroporated into M. smegmatis mc2155 (26, 27), and the
cells were plated on 7H10(+) agar plates containing 10 ,ug of
kanamycin per ml. Approximately 104 clones per gLg ofDNA
were obtained. After 5 days of incubation at 37°C, individual
colonies of kanamycin-resistant M. smegmatis were patched
onto 7H10(+) agar plates containing 25 ,ug of kanamycin per
ml and allowed to incubate for 4 to 5 days. These clones
were picked and placed on Whatman no. 40 cellulose filter
paper. The filters were then subjected to colony dot blot
enzyme-linked immunosorbent assay (ELISA) (2) employing
the serovar 2-specific CS-17 monoclonal antibody (MAb)
(24).
Mapping of the ser2 gene cluster. The pJTB21 cosmid was
digested with the restriction enzymes EcoRI, BamHI, and
PstI (19). DNA fragments corresponding to the M. avium
insert were purified by electroelution (13) and labeled with
digoxigenin by using a Genius kit. A second probe was
constructed by digesting pJTB21 with DraI plus Sacl and
labeling the isolated insert fragment with 32P via random
oligonucleotide primers. E. coli X2764 cells were infected
with the phage particles containing the M. avium library and
grown at 30°C on Luria-Bertani plates containing 25 gg of
kanamycin per ml (15). Approximately 7,000 E. coli recom-
binant colonies were lifted onto nitrocellulose filters, lysed,
and hybridized with the pJTB21 probes (19). Positive clones
were isolated and grown in superbroth with 25 ,ug of kana-
mycin per ml at 30°C. The recombinant cosmids were
isolated as circular DNA and mapped with restriction en-
zymes DraI, ClaI, HindIII, and SspI. Additionally, each
recombinant cosmid was electroporated into M. smegmatis
mc2155 and the M. smegmatis transformants were screened
for serovar 2 GPL expression by colony dot blot ELISA and
gas chromatography (GC) of the GPL-associated sugars.
Isolation and purification of GPLs. M. avium serovar 2 was
grown as previously described (20). M. smegmatis:pYUB18
and M. smegmatis:M. avium recombinant clones were
grown on 7H10(+) agar plates (15 by 150 mm) containing 25
,ug of kanamycin per ml for 5 to 6 days at 37°C. Cells were
scraped from plates, autoclaved, and lyophilized. Lipids
were extracted with CHCl3-CH30H (2:1) and subjected to a
mild alkali treatment which, by destroying nonspecific acyl-
glycerols, served as a purification step for the GPLs (20).
The resulting lipids were applied to columns (25 by 1.5 cm)
of silicic acid-Celite (2:1) and eluted with increasing concen-
trations of CH30H in CHCl3 (8); the total GPL population
from each strain was collected in the 25% CH30H eluate.
Total GPL (10 mg), in CHCl3, was loaded onto an Alltech
Econosphere high-pressure liquid chromatography (HPLC)
column (4.6 by 250 mm) packed with 5 ,um of silica. The
individual ns- and ssGPLs were eluted with increasing
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FIG. 2. Screening of M. smegmatis transformants with the M. avium serovar 2-specific MAb CS-17. (A) Initial screening of M. smegmatis
transformed with the pYUB18:M. avium library, resulting in identification of the MA21-21 clone. (B) Secondary screening of M. smegmatis
transformed with pJTB21. The negative (-) and positive (+) controls are M. smegmatis:pYUB18 and M. avium serovar 2, respectively.
concentrations of CH30H in CHCI3 (20). Fractions were
examined for purity by thin-layer chromatography in CHCl3-
CH30H (9:1) (3).
Other analytical methods. The amino acid compositions of
the various total and purified GPL fractions were determined
by GC-mass spectrometry (MS) of the N,(O)-heptafluoro-
butyryl isobutyl derivatives (14, 17) on an HP-1 capillary
column by using a Hewlett-Packard model 5890 gas chro-
matogram and model 5970 mass detector (20). The total and
purified GPL fractions were also analyzed for their sugar
compositions by GC-MS of the alditol acetate derivatives
(20) on a DB-23 capillary column. Fast atom bombardment
(FAB)-MS was performed on 10-gg samples of selected GPL
fractions on a 3-nitrobenzyl alcohol matrix spiked with 1 ,lI
of 0.1 M KCl by using a VG 7070 extra-high-frequency mass
spectrometer and an ion saddle field gun operated at 7 to 8
kV and 1 mA with xenon gas (16, 21).
C H
I
RESULTS
Construction and screening of the M. avium cosmid library.
A major obstacle in expressing recombinant secondary gene
products in mycQbacteria has been the inability to clone the
required complex of genes. In the present instance, the
capability to clone genes for glycosyl- and methyltrans-
ferases and possibly for enzymes responsible for de novo
synthesis of specific sugar residues had to be developed. In
order to clone the expected large multigene segment, we
chose the E. coli-Mycobacterium shuttle cosmid vector
pYUB18 (26, 27). The genomic library of M. avium serovar
2 DNA was constructed first in E. coli by utilizing bacterio-
phage X-mediated packaging. The transduction of E. coli
produced approximately 6,700 kanamycin-resistant E. coli
clones containing recombinant cosmids with M. avium in-
serts of 32 to 40 kb; the efficiency of this transduction was
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FIG. 3. Functional mapping of the ser2 gene cluster. Restriction endonuclease maps of the cloned M. avium inserts are presented with a
summary of results from the application of colony dot blot ELISA and GC to the GPLs from the recombinant clones that helped define the
functional ser2 region. Abbreviations: C, ClaI; H, Hindlll; S, SspI; N/D, not done. Symbols: -, no R-ssGPL-2 detected; +, weak R-ssGPL-2
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FIG. 4. GC of alditol acetates derived from the sugars of the various GPL-containing fractions. (A) M. avium serovar 2; (B) M.
smegmatis:pYUB18; (C) MA21-21. Details of derivatizations and chromatography conditions are provided in the text. Istd, internal standard
of 6-O-methylgalactose.
calculated to be 1.8 x 104 transformants per ,ug of insert
DNA. Covalently closed circular recombinant cosmids were
isolated from E. coli and electroporated into M. smegmatis
mc2155. Upon screening of 1,200 kanamycin-resistant M.
smegmatis clones, only one (MA21-21) reacted with the
CS-17 serovar 2-specific MAb (Fig. 2A). This recombinant
clone contained a 44-kb cosmid which was termed pJTB21.
After isolation from MA21-21 and amplification in E. coli
X2764, pJTB21 was electroporated back into M. smegmatis
mc2155, resulting in a 100% cotransformation frequency of
kanamycin resistance with serovar 2 activity (Fig. 2B). This
exercise demonstrated that the pJTB21 cosmid contained
those M. avium serovar 2-specific genes necessary for syn-
thesis of the antigenic segment of the ssGPL-2, i.e., the
distal 2,3-di-O-methyl-a-L-fucopyranosyl-(1-->3)-a-L-rham-
nopyranosyl [2,3-Me2-a-L-Fucp-(1--3)-a-L-Rhap] disaccha-
ride (8, 9, 24).
Mapping of the ser2 gene cluster. In order to map the
minimal contiguous M. avium DNA fragment necessary for
expression of the serovar 2-specific oligosaccharide, probes
were derived from the M. avium insert of pJTB21. Applica-
tion of these probes yielded 22 positive E. coli transformants
containing individual pYUB18:M. avium cosmids. After
isolation from E. coli, each cosmid was transformed into
M. smegmatis, and the resulting M. smegmatis:M. avium
clones were screened with the CS-17 MAb. Of the 22 clones,
3 (pJTB22, pJTB41, and pJTB211) produced a positive
reaction. However, as summarized in Fig. 3, the degree of
reactivity with the CS-17 MAb varied among these clones,
suggesting altered levels of oligosaccharide expression. The
alkali-stable GPLs were isolated from each clone and exam-
ined by GC for the presence of the serovar 2-specific sugars.
As expected, the clones containing pJTB21, pJTB22, and
pJTB41 possessed the serovar 2-specific sugars, Rha and
2,3-Me2-Fuc (Fig. 3). Small quantities of these sugars were
also observed in the GPLs from a clone that did not react
with the CS-17 MAb; this clone contained cosmid pJTB11
(Fig. 3). Functional mapping of the DNA of pJTB21 and the
additional 22 cosmids resulted in the recognition of an M.
avium genomic region of approximately 60 kb, of which a
48-kb segment is depicted in Fig. 3. The insert in the original
serovar 2 GPL-producing cosmid, pJTB21, was estimated to
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nsGPL-2 |nsGPL-M.smeg.
A j-R-ssGPL-2
SsGPL-2-
1 2 3 4
FIG. 5. Thin-layer chromatography of the native and recombi-
nant GPLs. Lanes: 1, purified M. avium ssGPL-2; 2, total GPL
population from M. avium serovar 2; 3, purified major R-ssGPL-2
from MA21-21; 4, total GPL population, both native and recombi-
nant, from MA21-21. The lipids were resolved on a silica gel
thin-layer chromatography plate in CHCl3-CH30H (9:1).
be 32 kb, and, of this, 22 to 27 kb appeared to be necessary
for the production of the serovar 2-specific segment of its
GPL molecule (Fig. 3). We have termed this region the ser2
gene cluster. A comparison of the ELISA and GC results
with maps of the inserts (Fig. 3) indicates that pJTB11,
pJTB22, and pJTB211 are devoid of those sequences on the
right side of the gene cluster deemed necessary for increased
expression of the ssGPL-2. Expression seems not to be
influenced by vector sequences, since the two inserts of
pJTB22 and pJTB211 were cloned in opposite orientations in
pYUB18. Thus, the right segment of this gene cluster may be
a regulatory region.
Chemical evidence for the generation of a recombinant
GPL. In order to lend chemical weight to the immunological
evidence for the presence of the serovar 2 determinant in
recombinant M. smegmatis, the total GPLs from M. avium
serovar 2, the transformed M. smegmatis containing pJTB21
(MA21-21), and control M. smegmatis containing pYUB18
were isolated and analyzed by a number of chemical means.
GC-MS revealed that the GPLs of the recombinant MA21-
21 possessed those sugars that typify the M. smegmatis
nsGPLs, namely, 2,3,4-Me3-Rha, 3,4-Me2-Rha, and 6-dTal,
as well as 2,3-Me2-Fuc and Rha (Fig. 4), i.e., the sugars
characteristic of the serovar 2-specific oligosaccharide.
Also, large amounts of 3-Me-Rha were evident, the origin of
which is not known at this time. Individual GPLs from each
organism were purified by HPLC. The presence of the
tetrapeptide core was confirmed by the observation that all
contained D-Phe, D-allo-Thr, D-Ala, and L-alaninol in equi-
molar quantities (5, 6). Thin-layer chromatography demon-
strated that the purified ssGPL-2 migrated directly below its
nonspecific relatives (Fig. 5, lanes 1 and 2), consistent with
previous observations (8, 9). The purified R-ssGPL-2 from
MA21-21 was shown to be less polar than the corresponding
M. avium ssGPL-2 (Fig. 5, lanes 1 and 3), most likely
reflecting differences in the fatty acyl content. GC-MS
analysis of the sugars from the purified R-ssGPL-2 confirmed
the presence of 2,3,4-Me3-Rha, 6-dTal, Rha, and 2,3-Me2-
Fuc (data not shown) and thus the presence of the serovar
2-specific oligoglycosyl unit in the recombinant glycolipid.
The presence of the 2,3,4-Me3-Rha unit in R-ssGPL-2
indicated that the core originated in M. smegmatis (Fig. 1B),
whereas chemical proof of the presence of Rha and 2,3-Me2-
Fuc supported the antigenic evidence that the distal segment
of the oligosaccharide originated in the M. avium serovar 2
genome (Fig. 1A). In order to confirm the proposed structure
of the R-ssGPL-2, FAB-MS, with its potential to provide
structural information about the holistic molecule, was em-
ployed (16, 21). A (M+K)+ pseudomolecular ion at mlz 1509
was observed (Fig. 6A), supporting the evidence for a GPL
endowed with the serovar 2-specific oligosaccharide: a 2,3,4-
Me3-Rha unit linked to L-alaninol and an amino-terminal-
linked saturated C28 mono-hydroxy fatty acid (1). One of the
major nsGPLs isolated from the host M. smegmatis also
contained 2,3,4-Me3-Rha and 6-dTal and showed an
(M+K)+ ion of mlz 1189 (Fig. 6B), demonstrating the
presence of an nsGPL with an amide-linked saturated C28
mono-hydroxy fatty acid in M. smegmatis, presumably the
template for serovar 2-directed glycosylation.
DISCUSSION
This landmark study represents the first reported cloning
of genes responsible for the synthesis of complex cell wall
structures of mycobacteria. Thus, genes from a member of
the M. avium complex were successfully expressed in M.
smegmatis, and the resulting products were shown to reflect
the serotypic identity of the parental M. avium. The respon-
sible genes were mapped to a 22- to 27-kb contiguous M.
avium genomic fragment, the so-called ser2 gene cluster.
Biochemical and immunochemical analyses of M. smegma-
tis clones possessing the pJTB21 and pJTB208 cosmids
indicate that the left terminus of ser2 is contained within a
4-kb region, whereas, according to analysis of pJTB11 and
pJTB22, the right terminus of ser2 mapped to a 1.5-kb
region. Also, the decreased expression of the serovar 2-spe-
cific oligosaccharide with increased deletions of the right
terminus of the ser2 gene cluster points to a possible region
of regulation for gene expression.
Although the ser2 cluster must possess the genes required
for serovar 2-specific oligosaccharide biosynthesis, the 22- to
27-kb fragment is larger than expected for the two to three
glycosyltransferases and methyltransferases expected to fa-
cilitate synthesis of the oligoglycosyl unit. Thus, this gene
cluster may contain multiple operons or it may encompass
the genes required for the de novo synthesis of fucose and
rhamnose, perhaps analogous to the Salmonella rfb operon
(4, 28, 31). Conceivably, the ser2 gene cluster could contain
the genes required for synthesis of the GPL core. However,
if this was so, the R-ssGPL-2 should possess an M. avium-
type core rather than an M. smegmatis-type core. Chemical
analysis of the R-ssGPL-2, by GC-MS and FAB-MS, dem-
onstrated the presence of a 2,3,4-Me3-Rha unit and a satu-
rated C28 mono-hydroxy fatty acyl unit, the same substitu-
ents attributed to the simple GPLs of M. smegmatis (1, 12,
22) but not to those of M. avium (3, 6, 22). The chemical
characteristics of the R-ssGPL-2 also indicate that the sim-
plier monoglycosylated GPLs act as biosynthetic precursors
of the multiglycosylated GPLs of M. avium, a relationship
that had been assumed but never demonstrated. The chem-
ical evidence also suggests that the genes encoding the
synthesis of the components of the GPL core, namely,
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|I H53CH(OH)CO - NH - Phe - aThr - Ala -Aino - - 2,3,4 - Me3Rha|
0
A 6d Tai: - Rha - 2, 3 - 2Fuc
1509 (M+K)+
1493 (M+Na)'
m/z
| CHWCH(OH)CO-NH-Phe-aThr-aAla-nnol-O-2,3,4-Me3Rha
O 1189 (M+K)+
B 6d Tal
1173 (M+Na)t
mlz
FIG. 6. FAB-MS of purified GPLs. (A) The FAB-MS of R-
ssGPL-2 from MA21-21. The depicted structure of the major
R-ssGPL-2 isolated from MA21-21 has a formula weight of 1,470, in
accordance with observed molecular ions. The structural compo-
nents outlined in the solid box originate in the M. smegmatis
genome, whereas those in the dashed box originate in the M. avium
serovar 2 genome. (B) FAB-MS of an nsGPL purified from M.
smegmatis:pYUB18 lipid. The depicted structure of this nsGPL has
a formula weight of 1,150, in accordance with observed molecular
ions.
unusual fatty acids and amino acids, are located within an
operon other than ser2. The separation of operons respon-
sible for the synthesis of individual components of a complex
molecule is not uncommon; for instance, the rfa operon
responsible for the synthesis of the lipopolysaccharide core
is separate from the rjb operon for 0-antigen synthesis (18).
Clearly, elucidation of the relationship of genes encoding
serovar-specific oligosaccharides to those governing the
expression of the communal core requires further work.
Sequence analysis, once specific genes within the ser2 gene
cluster are identified, should be of considerable benefit in
this sense.
M. smegmatis, with a growth rate 10 times higher than
that of mycobacterial pathogens (25), was chosen in the
present study as the preferred host for cloning M. avium
genes because its cell wall is similar in several key respects
to that of M. avium, and, unlike M. avium, it is genetically
manipulable. Application of this strategy to other major
mycobacterial pathogens, Mycobacterium leprae and Myco-
bacterium tuberculosis, should greatly facilitate an analysis
of the pathways leading to the biosynthesis of their own
distinctive cell wall entities (7, 20). In addition, this initial
study of genetic mechanisms underlying the biosynthesis of
the exceptionally complex glycoconjugates of mycobacterial
cell walls should provide new approaches to the age-old
issue of the roles of such entities in pathogenesis and to the
problem of intractable chemotherapy of M. avium infec-
tions.
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